GMED
Globus MedicalCNYSE / Health Care Equipment & Services
Last Price
At close
2026-07-18
Current thesis
The primary-company read is constructive: Q1 revenue rose 27.0%, base business ex-Nevro grew 13.2%, and full-year non-GAAP EPS guidance moved up to $4.70-$4.80 [#8-K-2026-05-07]. The stronger direct-peer frame is spine and orthopedics rather than generic medtech, which keeps the bull case tied to share gains, procedure volumes, and enabling-technology adoption.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.3.
What can break
Competition is a concrete execution risk: Globus named Medtronic, DePuy Synthes, Stryker, Zimmer Biomet, Smith + Nephew, Alphatec, Orthofix, Integra LifeSciences, ZimVie, VB Spine, Boston Scientific, and others as competitors in musculoskeletal disorders [#10-K-2026-02-24].
Momentum
19
Value
63
Sentiment
64
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $92.00 · Bull $106.00 · Bear $74.00
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $104.50
Why
Momentum19 · Δ7d +7.9
Value63 · Δ7d +0.3
Sentiment64 · Δ7d -1.9
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
19
26% active weight
Current posture
7d trendImproving
Δ7d
+7.9
Δ21d
+3.5
Value
63
39% active weight
Current posture
7d trendFlat
Δ7d
+0.3
Δ21d
+2.9
Sentiment
64
34% active weight
Current posture
7d trendSoftening
Δ7d
-1.9
Δ21d
+11.4
Why this grade
Composite grade C. Momentum 19.5 / Value 63.5 / Sentiment 64.3
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$10.31B
Beta
1.06
Shares Out
135.67M
P/E (TTM)
29.2
P/S (TTM)
4.37
P/FCF (TTM)
21.25
Rev YoY
+27.0%
EPS YoY
+66.6%
Gross Margin
+64.1%
Op Margin
+17.5%
Net Debt
-$437.8M
Current Ratio
4.56
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology